AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
7min chapter
Fed in Holding Pattern on Interest Rates, December Cut Possible
Bloomberg Businessweek
Analyzing Eli Lilly's Performance and Market Competition
The chapter delves into investor concerns over Zepbana shortages at Lilly, discussing the company's reassurance of meeting demand. It focuses on Lilly's key drugs like Monjura and Zepbound, evaluating their impact on the company's revenue and supply chain challenges. Additionally, it explores the competitive landscape with companies like Boringa Al-Golheim and Amgen, shifting industry dynamics from COVID to areas such as weight loss, heart disease, and mental health.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode